Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,993,776
+$957,407 QoQ
Shares Held
2,496
+12.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.98%
of 13F equity value
Holder Rank
#2,133
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fourth Dimension Wealth, LLC holds $5,329,181 across 12 Drug Manufacturers - General names. LLY ranks #1 (56.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,496 | $2,993,776 | |
| 2 | JNJ |
Johnson & Johnson
|
4,658 | $1,182,991 | |
| 3 | ABBV |
AbbVie Inc.
|
2,496 | $628,092 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,329 | $170,776 | |
| 5 | PFE |
Pfizer Inc
|
3,540 | $85,243 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
643 | $81,236 | |
| 7 | AMGN |
Amgen Inc
|
186 | $67,354 | |
| 8 | NVS |
Novartis AG
|
400 | $62,688 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,993,776 | 2,496 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $2,036,369 | 2,214 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,508,303 | 2,334 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,780,842 | 2,334 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,859,957 | 2,386 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,303,285 | 1,578 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $972,720 | 1,260 | Shares | Sole | 2025-02-18 | |
| No filing history on record for this holder in this stock. | ||||||